国际循环手机网-搜索

首页	会议	新知	争鸣
名家	名刊	指南	病例

关键词

普伐他汀和阿司匹林降低心血管疾病危险的叠加效应：二级预防试验的随机化和观察性对比及荟萃分析 Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
冠状动脉钙化指数有助于预测心血管风险 Coronary Artery Calcium Scores Aid in Cardiovascular Risk Prediction
PREVEND IT研究：ACE抑制剂有利于因心血管疾病而并发肾损害的患者 ACE Inhibitor Use Shows Benefit in Microalbuminuria Without Clinical Signs of Vascular Disease
国际动脉粥样硬化会议：匹格列酮降低2型糖尿病患者的心血管风险 Pioglitazone Improves Cardiovascular Risk Profile of Patients With Type 2 Diabetes
医生们在胆固醇药物的问题上存在分歧 Doctors Divided Over Cholesterol Drugs Study 存在争议的是：在防止心血管事件发生上不能说哪种药物更好 It doesn’t say which medicine better at halting cardiovascular events
在胰岛素抵抗动脉粥样硬化研究(IRAS)中比较载脂蛋白B和低密度脂蛋白胆固醇与其它心血管疾病危险因素的关系 Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
糖尿病或空腹血糖受损患者长期服用普伐他汀进行心血管事件二级预防：LIPID试验的结果 Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
依那普利、坎地沙坦、美托洛尔单用或合用对充血性心衰患者心室重构的影响之比较 Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.
血液中的化学物质是心脏疾病的指示剂？ Is chemical a sign of heart disease?
PROVE-IT: 与每天40 mg 普伐他汀相比，每天80 mg阿托伐他汀可使ACS患者的主要心血管事件风险降低16% PROVE-IT: Atorvastatin 80 mg reduces major CV events by 16% compared with pravastatin 40 mg in ACS patients
小剂量雷米普利影响2型糖尿病患者心血管及肾脏疾病的预后，并可促进尿白蛋白的排泄：一项随机双盲的安慰剂对照临床试验（DIABHYCAR）研究 Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised,double blind, placebo controlled trial (the DIABHYCAR study).
炎性标记物水平升高可预测2型糖尿病患者的心血管性死亡 Elevated Inflammatory Markers Predict Cardiovascular Death For Type 2 Diabetes Patients
强化降脂治疗—心血管疾病预防的重大转变 Intensive Statin Therapy — A Sea Changein Cardiovascular Prevention
代谢综合征可改变女性患者冠状动脉疾病所致的心血管病风险：一份来自妇女缺血综合征评估的报告 Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.

声明:登陆《国际循环》手机网不收业务信息费，只产生运营商收取的上网流量费。
返回顶端| About Us | 客服中心 |收藏本站
WapURL手机网址（wap.icirculation.com)